Assessment of Mitral Stenosis Severity
Echocardiography is the preferred method for diagnosing mitral stenosis and assessing its severity, with valve area measurement by planimetry being the reference standard for determining severity. 1
Primary Echocardiographic Parameters for Severity Assessment
Mitral valve area (MVA) is the most direct measure of stenosis severity:
Mean transmitral gradient is an important hemodynamic parameter:
Pulmonary artery systolic pressure (PASP) reflects hemodynamic consequences:
Imaging Techniques for Assessment
Two-dimensional transthoracic echocardiography (TTE) should be used to:
- Measure valve area by planimetry (reference standard) 1
- Assess valve morphology including mobility, thickness, calcification, and subvalvular fusion 3
- Calculate Wilkins' score (1-4 points for each: leaflet mobility, thickness, calcification, and subvalvular thickening) to determine suitability for intervention 3
Doppler echocardiography should be used to:
Stress Echocardiography for Borderline Cases
Exercise echocardiography is indicated in:
Criteria for hemodynamically significant mitral stenosis during stress:
Common Pitfalls and Caveats
- Heart rate effects: Tachycardia can artificially increase the gradient without changing the actual severity of stenosis 2
- Cardiac output effects: Low cardiac output states may result in low gradients despite severe stenosis 2
- Atrial fibrillation: Irregular rhythm can cause variable gradients; multiple measurements should be averaged 2
- Concomitant valve disease: Associated mitral regurgitation or aortic valve disease may affect assessment 1
- Body size considerations: Indexed valve area may be more appropriate in patients with large body surface area 1
Advanced Imaging Techniques
Transesophageal echocardiography (TOE) is indicated:
3D echocardiography provides:
Remember that mitral stenosis severity assessment should integrate multiple parameters rather than relying on a single measurement, as discordance between valve area and gradient can occur due to various hemodynamic factors 2.